The Business of Attention: Inside Forge's Buyout of Becker's Healthcare

NEW YORK, NY – September 22, 2026 — In the modern corporate economy, influence is a highly monetizable asset. While the broader public fixates on consumer tech and generative artificial intelligence, a much quieter, highly lucrative consolidation is happening in the business-to-business sector. Today, Forge—the B2B events and media conglomerate backed by Apollo Funds—announced a definitive agreement to acquire Becker’s Healthcare from private equity firm Pamlico Capital.

The transaction brings the premier publisher for hospital and health system executives under the same corporate umbrella as Fierce Healthcare and Life Sciences. By uniting these two entities, the newly minted media behemoth has essentially created an end-to-end monopoly on the attention of the medical industry's most powerful decision-makers.

From a strategic standpoint, this is not merely a media acquisition; it is a calculated infrastructure play. By stripping away the digital hype and looking at the raw mechanics of corporate purchasing, the logic becomes undeniable. The entity that controls the information flow to both the pharmaceutical researchers developing new drugs and the hospital administrators purchasing them holds immense commercial leverage.

The "Bench to Bedside" Media Pipeline

To understand the gravity of this merger, one must look at the traditional fragmentation of medical publishing. For years, the industry was bifurcated. Upstream coverage—biotechnology, pharmaceutical R&D, and clinical trials—was dominated by brands like Fierce, which Forge inherited through its acquisition of Questex. Downstream operations—hospital management, payer dynamics, and ambulatory surgery centers—were the undisputed domain of Becker’s Healthcare.

Founded by Scott Becker and led since 2010 by CEO Jessica Cole, the Chicago-based publisher built an empire by catering strictly to the operational realities of the C-suite. Through its 16 annual conferences and a relentless daily cadence of digital newsletters, the brand reaches over 1.5 million leaders and welcomes more than 15,000 live event attendees each year.

"Becker’s sets the agenda for the business of healthcare," said Paul Miller, Chief Executive Officer of Forge, in the official announcement. "Its daily reporting reaches the leadership of every major health system, hospital and payer in the country, and its stages are where those leaders gather. Combined with Fierce Healthcare and Life Science’s reach, we will be able to serve healthcare decisionmakers across the full continuum of care, with significant opportunity to grow as these markets grow."

This "bench to bedside" integration means that a commercial vendor—whether a medical device manufacturer or an enterprise software firm—can now negotiate a single marketing contract to reach both clinical development partners and downstream hospital purchasing committees.

"When you control the room where hospital CEOs learn about their margins, and you control the inbox where pharma executives track clinical trials, you essentially own the commercial pipeline," noted one veteran healthcare media buyer who requested anonymity to discuss industry pricing dynamics. "Ad agencies are going to have to completely rethink how they negotiate sponsorships, because the leverage just shifted entirely to the publisher."

Apollo's Rapid Roll-Up Strategy

The acquisition of Becker’s is a testament to the aggressive timeline of Apollo Global Management's B2B roll-up strategy. Forge is barely a season old. The enterprise was officially formed in July 2026, following Apollo's simultaneous $1.5 billion take-private buyout of Emerald Holding and the acquisition of Questex. Backed by a $765 million syndicated term loan facility, the private equity giant signaled its intent to build a massive, cross-industry events and data platform.

Just weeks after rebranding the combined entity as Forge, the corporate parent has executed its first major bolt-on acquisition. While financial terms of the Becker's deal were not disclosed, industry benchmarks provide a clear picture. Specialized business media platforms with high gross margins and proprietary live event assets typically trade between 3.0x and 4.5x trailing revenue. With the acquired asset's estimated annual revenue sitting comfortably in the $40 million to $60 million range, the implied transaction value likely falls between $140 million and $220 million.

For Pamlico Capital, which acquired a majority interest in the healthcare publisher back in July 2017, the exit represents a significant realization of value. Over their nine-year holding period, the asset expanded from five annual conferences to 16, weathering the pandemic-era disruption to live events and emerging with a highly profitable, digitally integrated portfolio.

"Becker’s was built by staying relentlessly focused on the needs of the people who run healthcare, and by a team that treats that as a personal responsibility," Cole stated regarding the transition. "Joining Forge gives our team a bigger platform to do exactly that, with more reach, more data and more ways to connect our audiences across the industry."

First-Party Data and the AI-Proof Event

Beyond the sheer scale of combining over 35 annual live conferences, the underlying currency of this transaction is first-party data. In an era where third-party tracking cookies are obsolete and generative AI is flooding the internet with synthetic content, verified human attention is trading at an absolute premium.

Private equity firms view specialized B2B media as uniquely insulated from technological disruption. A large language model can summarize a regulatory filing, but it cannot replicate the high-stakes networking that occurs at a VIP executive roundtable in Chicago. Furthermore, enterprise vendors are willing to pay exorbitant rates for verified, opt-in subscriber data linked to specific corporate titles, such as a health system's Vice President of Supply Chain.

"Becker’s is exactly the kind of business we looked to invest in when we formed Forge: a category leader with an exceptional management team, deep audience trust, durable first-party data, marquee live events and a year-round engagement model, operating in a market with powerful long-term tailwinds," noted Shahid Bosan, Managing Director at Apollo.

By merging the legacy Questex audience taxonomy with Becker's 1.5 million monthly executive contacts, the parent company is building an enterprise customer data platform of unprecedented depth. This allows for a "365-day engagement" model, where a digital interaction in February can be tracked, nurtured, and converted into a premium conference sponsorship in October.

Navigating the New Leadership Landscape

For the hospital administrators and industry executives who rely on these platforms, the immediate operational impact will likely be subtle. The acquiring firm has a track record of preserving the brand equity of its individual properties. The Chicago-based publisher will retain its distinct voice, its high-volume executive briefings, and its leadership team, ensuring continuity for its loyal readership.

However, the broader implications for the healthcare sector are profound. As the underlying industry grows increasingly complex—driven by an aging population, shifting care models, and technological advances—the need for trusted information becomes critical. The consolidation of that information into a single, highly capitalized corporate entity means that the narratives shaping medical leadership will be curated by a smaller, more powerful group of stakeholders.

As we strip away the corporate jargon, the reality of the Forge and Becker's integration is a masterclass in modern pragmatic business. It proves that while technology changes how we work, the foundational need for human connection, verified data, and targeted professional communities remains the most reliable driver of the corporate bottom line.